Michael Allon

A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial

National Institute on Aging · R01

PI · $5.6M · Wake Forest University Health Sciences

Barriers to Arteriovenous Fistula Use in Black Hemodialysis Patients

National Institute on Minority Health and Health Disparities · R01

Contact PI · $2.3M · University of Alabama at Birmingham

Choice of Vascular Access and Patient Outcomes Among Older Hemodialysis Patients

National Institute of Diabetes and Digestive and Kidney Diseases · R21

Contact PI · $432.1K · University of Alabama at Birmingham

Vascular Abnormalities in Patients Receiving a Dialysis Access.

National Institute of Diabetes and Digestive and Kidney Diseases · R01

Contact PI · $1.5M · University of Alabama at Birmingham

The Arteriovenous Vascular (AV) ACCESS Trial

Principal investigator · Active not recruiting

Wake Forest University Health Sciences

Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes

Study director · Unknown

National Kidney Foundation, United States